Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

Clinical trial NCT02952820 · COMPLETED

Trial details

NCT number: NCT02952820
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Insomnia Disorder

Start date: 2016-11-15
Primary completion: 2019-01-08
Enrollment: 971

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.